Abstract
Atypical antipsychotics, including olanzapine, were originally expected to reduce the risk of haematological toxicity and to be safe alternatives to clozapine. We report a case of patient who developed leucopenia and neutropenia during treatment with olanzapine.
MeSH terms
-
Aged
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Benzodiazepines / adverse effects
-
Benzodiazepines / therapeutic use
-
Depressive Disorder, Major / drug therapy
-
Humans
-
Leukopenia / chemically induced*
-
Male
-
Neutropenia / chemically induced*
-
Olanzapine
Substances
-
Antipsychotic Agents
-
Benzodiazepines
-
Olanzapine